The American pharmaceutical company, Pfizer, together with scientists from the Medical Branch of the University of Texas (USA), made an analysis on the N501Y mutation in the peak protein of the variant found in the United Kingdom.
The American pharmaceutical company, Pfizer, together with scientists from the Medical Branch of the University of Texas (USA), made an analysis on the N501Y mutation in the peak protein of the variant found in the United Kingdom.